Atypical presentations of orbital cellulitis caused by methicillin-resistant Staphylococcus aureus.

Purpose: To evaluate the epidemiologic and clinical features of orbital cellulitis caused by methicillin-resistant Staphylococcus aureus (MRSA).

Design: Multicenter, retrospective case series.

Participants: Fifteen patients with culture-positive MRSA orbital cellulitis.

The use of prostaglandin analogs in the uveitic patient.

Glaucoma is a disease process characterized by progressive optic nerve damage and corresponding visual field loss. It may be further categorized into either primary open-angle glaucoma or secondary glaucoma. These secondary glaucomas include glaucomas associated with uveitis and inflammation.

Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy.

Purpose: To evaluate the effects of multiple intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents on the thickness of the retinal nerve fiber layer (RNFL) in patients with wet age-related macular degeneration (ARMD).

Design: Retrospective, observational, consecutive case series of patients diagnosed with wet ARMD.

Methods: Forty-one eyes of 37 consecutive patients (25 female and 12 male; mean age 79.

Anti-VEGF therapy for glaucoma.

Purpose Of Review: The role of antivascular endothelial growth factor (anti-VEGF) agents in treating various ophthalmic diseases is currently being investigated. There have been many advances in the understanding of how anti-VEGF agents work and speculation on when to implement them clinically for neovascular glaucoma. Recent studies exploring the utility of anti-VEGF agents for wound modulation after trabeculectomy reveal promising results.

Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.

Purpose: To quantify changes in tear break-up time (TBUT), corneal staining and ocular surface disease index (OSDI) in glaucoma patients after switching therapy from latanoprost with 0.02% benzalkonium chloride (BAK) to travoprost with sofZia().

Methods: Prospective consecutive case series evaluating patients before and 8 weeks after switching from latanoprost with BAK to travoprost with sofZia() in patients with baseline TBUT less than 6 seconds.

Resolution of pityriasis rubra pilaris-induced cicatricial ectropion with systemic low-dose methotrexate.

Purpose: To report a case of pityriasis rubra pilaris (PRP)-induced bilateral lower eyelid cicatricial ectropion that resolved with systemic low-dose methotrexate.

Design: Observational case report.

Methods: A retrospective case review of a patient with cicatricial ectropion caused by PRP.